MMSL 2024, 93(4):377-387 | DOI: 10.31482/mmsl.2023.042

THE DIABETIC-ANEMIA NEXUS: IMPLICATIONS FOR CLINICAL PRACTICEReview article

Ghada M. Ahmed1, Mohammed N. Abed ORCID...2,5*, Fawaz A. Alassaf ORCID...3,4,5
1 Nineveh Health Directorate, Mosul, Nineveh province, Iraq (ghadaalsawaf87@gmail.com)
2 Department of Pharmaceutical Chemistry (m.n.abed@uomosul.edu.iq)
3 Department of Pharmacology and Toxicology (Fawaz.Alassaf@uomosul.edu.iq)
4 College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq
5 University of Mosul, College of Pharmacy, Mosul, Nineveh province, Iraq

Objectives: Due to a variety of factors, individuals with diabetes are more likely to develop anemia. Chronic kidney disease, a frequent consequence of diabetes, is one of the key contributing factors. Diabetic neuropathy is another reason that can result in gastrointestinal bleeding and iron malabsorption. Healthcare providers must be aware of the connection between diabetes and anemia in order to closely monitor and treat both disorders and lessen their detrimental effects on general health and quality of life. This review sought to explore the underlying factors that lead to anemia in diabetic individuals, as well as the most prevalent kinds of anemia and suggested management approaches.

Methods: PubMed, Cochrane Library and Google scholar were searched to find all relevant articles published in English until October 2023, using the specified search phrases, and we then brought up and analyzed all of the papers that matched the requirements.

Results and conclusion: Collectively, managing anemia in diabetes patients is a difficult issue that calls for a multimodal approach. Early detection and effective therapy of anemia in diabetic patients depend on routine monitoring of the blood levels of hemoglobin, glycemic control, blood pressure, foot health, renal and retinal functions, neuropathy, and other comorbidities.

Keywords: Diabetes mellitus; Anemia; Erythropoietin

Received: May 30, 2023; Revised: October 19, 2023; Accepted: November 3, 2023; Prepublished online: December 18, 2023; Published: December 2, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ahmed, G.M., Abed, M.N., & Alassaf, F.A. (2024). THE DIABETIC-ANEMIA NEXUS: IMPLICATIONS FOR CLINICAL PRACTICE. MMSL93(4), 377-387. doi: 10.31482/mmsl.2023.042
Download citation

References

  1. Mahmood IH, Abed MN, Merkhan MM. Effects of blocking of angiotensin system on the prevalenceof metabolic syndrome in type 2 diabetic patients. Pakistan J Med Sci. 2012;29(1):140-143. Go to original source... Go to PubMed...
  2. Echeta CK, Awuchi CG, Kate Echeta C. Diabetes and the Nutrition and Diets for Its Prevention and Treatment: A Systematic Review and Dietetic Perspective Diabetes and the Nutrition and Diets for Its Prevention and Treatment: Heal Sci Res. 2020;6(1):5-19.
  3. Thomas M, Tsalamandris C, MacIsaac R, et al. Anaemia in Diabetes: An Emerging Complication of Microvascular Disease. Curr Diabetes Rev. 2005;1(1):107-126. Go to original source... Go to PubMed...
  4. Thomas MC, Cooper ME, Rossing K, et al. Anaemia in diabetes: Is there a rationale to TREAT? Diabetologia. 2006;49(6):1151-1157. Go to original source... Go to PubMed...
  5. Pappa M, Dounousi E, Duni A, et al. Less known pathophysiological mechanisms of anemia in patients with diabetic nephropathy. Int Urol Nephrol. 2015;47(8):1365-1372. Go to original source... Go to PubMed...
  6. Alassaf FA, Jasim MHM, Alfahad M, et al. Effects of Bee Propolis on FBG, HbA1c, and Insulin Resistance in Healthy Volunteers. Turkish J Pharm Sci. 2021;18(4):405-409. Go to original source... Go to PubMed...
  7. Kaiafa G, Veneti S, Polychronopoulos G, et al. Is HbA1c an ideal biomarker of well-controlled diabetes? Postgrad Med J. 2021;97(1148):380-383. Go to original source... Go to PubMed...
  8. English E, Idris I, Smith G, et al. The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review. Diabetologia. 2015;58(7):1409-1421. Go to original source... Go to PubMed...
  9. Bonakdaran S, Gharebaghi M, Mohammad V. Prevalence of anemia in type 2 diabetes and role of renal involvement. saudi J kidney Dis Transplant. 2011;22(2):286-290.
  10. Hardikar PS, Joshi SM, Bhat DS, et al. Spuriously High Prevalence of Prediabetes Diagnosed by HbA1c in Young Indians Partly Explained by Hematological Factors and Iron Deficiency Anemia. Diabetes Care. 2012;35(4):797-802. Go to original source... Go to PubMed...
  11. Barbieri J, Fontela PC, Winkelmann ER, et al. Anemia in Patients with Type 2 Diabetes Mellitus. Anemia. 2015;2015(2):1-7. Go to original source... Go to PubMed...
  12. Trevest K, Treadway H, der Cingel GH, et al. Prevalence and Determinants of Anemia in Older People With Diabetes Attending an Outpatient Clinic: A Cross-Sectional Audit. Clin Diabetes. 2014;32(4):158-162. Go to original source... Go to PubMed...
  13. Abed MN, Alassaf FA, Jasim MHM, et al. Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole. Pharmacology. 2020;1-7. Go to original source... Go to PubMed...
  14. Alfahad M, Qazzaz ME, Abed MN, et al. Comparison of Anti-Oxidant Activity of Different Brands of Esomeprazole Available in Iraqi Pharmacies. Syst Rev Pharm. 2020;11(05):330-334. Go to original source...
  15. Thanoon IAJ, Jasim MHM, Abed MN, et al. Effects of omega-3 on renal function tests and uric acid level in healthy volunteers. Lat Am J Pharm. 2021;40(10):2319-2323.
  16. Tsai S-F, Tarng D-C. Anemia in patients of diabetic kidney disease. J Chinese Med Assoc. 2019 Oct;82(10):752-755. Go to original source... Go to PubMed...
  17. Catrina S-B, Zheng X. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia. 2021;64(4):709-716. Go to original source... Go to PubMed...
  18. Gunton JE. Hypoxia-inducible factors and diabetes. J Clin Invest. 2020;130(10):5063-5073. Go to original source... Go to PubMed...
  19. Kaplan J, Sharma N, Dikdan S. Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease. Int J Mol Sci. 2018;19(2):389. Go to original source... Go to PubMed...
  20. Kuo I-C, Lin HY-H, Niu S-W, et al. Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney Disease. Sci Rep. 2016;6(1):20028. Go to original source... Go to PubMed...
  21. Szablewski L, Sulima A. The structural and functional changes of blood cells and molecular components in diabetes mellitus. Biol Chem. 2017;398(4):411-423. Go to original source... Go to PubMed...
  22. Nigam SK, Bush KT. Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling. Nat Rev Nephrol. 2019;15(5):301-316. Go to original source... Go to PubMed...
  23. Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron Deficiency Anemia in Chronic Kidney Disease. Acta Haematol. 2019;142(1):44-50. Go to original source... Go to PubMed...
  24. Yokusoglu M, Nevruz O, Baysan O, et al. The Altered Autonomic Nervous System Activity in Iron Deficiency Anemia. Tohoku J Exp Med. 2007;212(4):397-402. Go to original source... Go to PubMed...
  25. Cotroneo P, Maria Ricerca B, Todaro L, et al. Blunted erythropoietin response to anemia in patients with Type 1 diabetes. Diabetes Metab Res Rev. 2000;16(3):172-176. Go to original source...
  26. Bissinger R, Bhuyan AAM, Qadri SM, et al. Oxidative stress, eryptosis and anemia: a pivotal mechanistic nexus in systemic diseases. FEBS J. 2019;286(5):826-854. Go to original source... Go to PubMed...
  27. Qazzaz ME, Abed MN, Alassaf FA, et al. Insights into the perspective correlation between vitamin D and regulation of hormones: sex hormones and prolactin. Curr Issues Pharm Med Sci. 2021;34(4):192-200. Go to original source...
  28. Uche FI, Abed MN, Abdullah MI, et al. Isochondodendrine and 2'-norcocsuline: additional alkaloids from Triclisia subcordata induce cytotoxicity and apoptosis in ovarian cancer cell lines. RSC Adv. 2017;7(70):44154-44161. Go to original source...
  29. Fiorentino T, Prioletta A, Zuo P, et al. Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases. Curr Pharm Des. 2013;19(32):5695-5703. Go to original source... Go to PubMed...
  30. Waggiallah H, Alzohairy M. The effect of oxidative stress on human red cells glutathione peroxidase, glutathione reductase level, and prevalence of anemia among diabetics. N Am J Med Sci. 2011;344-347. Go to original source... Go to PubMed...
  31. Wang Y, Yang P, Yan Z, et al. The Relationship between Erythrocytes and Diabetes Mellitus. J Diabetes Res. 2021;2021:6656062. Go to original source... Go to PubMed...
  32. Alassaf FA, Alfahad M, Jasim MHM, et al. Insights into the Perspective Correlation between Vitamin D and Regulation of Hormones: Adrenal Hormones and Vasopressin. Lat Am J Pharm. 2022;41(11):2242-2247.
  33. Ergün B, Kutlugün AA, Ergün MÇ, et al. Investigation of the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on anemia in patients with normal or mildly low glomerular filtration rate. TURKISH J Med Sci. 2021;51(6):3047-3052.
  34. Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019;176(3):14092. Go to original source... Go to PubMed...
  35. Romano AD, Paglia A, Bellanti F, et al. Molecular Aspects and Treatment of Iron Deficiency in the Elderly. Int J Mol Sci. 2020;21(11):3821. Go to original source... Go to PubMed...
  36. Kim C, Bullard KM, Herman WH, et al. Association Between Iron Deficiency and A1C Levels Among Adults Without Diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2010;33(4):780-785. Go to original source... Go to PubMed...
  37. Qazzaz ME, Alfahad M, Alassaf FA, et al. Effects of omega-3 on thyroid function tests in healthy volunteers. Syst Rev Pharm. 2020;11(7):10-14.
  38. Alnori H, Alassaf FA, Alfahad M, et al. Vitamin D and Immunoglobulin E Status in Allergic Rhinitis Patients Compared to Healthy People. J Med Life. 2020;13(4):463-468. Go to original source... Go to PubMed...
  39. Zhao M, Yuan MM, Yuan L, et al. Chronic folate deficiency induces glucose and lipid metabolism disorders and subsequent cognitive dysfunction in mice. Nerurkar P V., editor. PLoS One. 2018;13(8):e0202910. Go to original source... Go to PubMed...
  40. Alassaf FA, Qazzaz ME, Alfahad M, et al. Effects of bee propolis on thyroid function tests in healthy volunteers. Trop J Pharm Res. 2022 Jan 24;20(4):859-863. Go to original source...
  41. Jasim MHM, Abed MN, Qazzaz ME, et al. Aspirin-aromatic amino acid conjugates as selective Cox-2 inhibitors: A docking study. Trop J Pharm Res. 2021;30(3):579-583. Go to original source...
  42. Nakasone H, Kako S, Endo H, et al. Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia. Hematology. 2009;14(6):361-365. Go to original source... Go to PubMed...
  43. Jandriæ Balen M, Lukenda V, Jandriæ I, et al. HbA1C - overall glycemia marker and hemolytic anemia indicator. Med Glas. 2012;9(2):406-408.
  44. Lum G. Artefactually Low Hemoglobin A 1C in a Patient with Hemolytic Anemia. Lab Med. 2010;41(5):267-270. Go to original source...
  45. James SH, Meyers AM. Microangiopathic Hemolytic Anemia as a Complication of Diabetes Mellitus. Am J Med Sci. 1998;315(3):211-215. Go to original source... Go to PubMed...
  46. Zhu Z, Chen H, Gill R, et al. Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report. J Med Case Rep. 2016;10(1):38. Go to original source... Go to PubMed...
  47. Furlong E, Carter T. Aplastic anaemia: Current concepts in diagnosis and management. J Paediatr Child Health. 2020 Jul;56(7):1023-1028. Go to original source... Go to PubMed...
  48. Wu F, Jing Y, Tang X, et al. Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients. Acta Diabetol. 2017;54(10):925-931. Go to original source... Go to PubMed...
  49. Khanbhai M, Loukogeorgakis S, Wright J, et al. Anaemia, inflammation, renal function, and the diabetic foot: What are the relationships? Diabet Foot J. 2012;15(4):150-158.
  50. Lee Y-G, Chang Y, Kang J, et al. Risk factors for incident anemia of chronic diseases: A cohort study. Reboldi G, editor. PLoS One. 2019;14(5):e0216062. Go to original source... Go to PubMed...
  51. Wang GS, Hoyte C. Review of Biguanide (Metformin) Toxicity. J Intensive Care Med. 2019;34(11-12):863-876. Go to original source... Go to PubMed...
  52. Donnelly LA, Dennis JM, Coleman RL, et al. Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study. Diabetes Care. 2020;43(10):2493-2499. Go to original source... Go to PubMed...
  53. Yang W, Cai X, Wu H, et al. Associations between metformin use and vitamin B 12 levels, anemia, and neuropathy in patients with diabetes: a meta-analysis. J Diabetes. 2019;11(9):729-743. Go to original source... Go to PubMed...
  54. Bell DSH. Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes. Diabetes, Obes Metab. 2022;24(8):1423-1428. Go to original source... Go to PubMed...
  55. Jasim MHM, Alfahad M, Al-Dabbagh BM, et al. Synthesis, Characterization, ADME Study and In-Vitro Anti-Inflammatory Activity of Aspirin Amino Acid Conjugates. Pharm Chem J. 2023;57(2):243-249. Go to original source...
  56. Al-dabbagh BM, Abed MN, Mahmood NM, et al. Anti-Inflammatory, Antioxidant and Hepatoprotective Potential of Milk Thistle in Albino Rats. Lat Am J Pharm. 2022;41(9):1832-1841.
  57. Della-Morte D, Palmirotta R, Rehni AK, et al. Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors. Pharmacogenomics. 2014;15(16):2063-2082. Go to original source... Go to PubMed...
  58. Blicklé JF. [Thiazolidinediones: clinical data and perspectives]. Diabetes Metab. 2001;27(2 Pt 2):279-285.
  59. Hirase N, Yanase T, Mu Y, et al. Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562. Leuk Res. 2000;24(5):393-400. Go to original source... Go to PubMed...
  60. Brown E, Heerspink HJL, Cuthbertson DJ, et al. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet. 2021;398(10296):262-276. Go to original source... Go to PubMed...
  61. Winiarska A, Knysak M, Nabrdalik K, et al. Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists. Int J Mol Sci. 2021;22(19):10822. Go to original source... Go to PubMed...
  62. Trevisan M, Fu EL, Szummer K, et al. Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction. Eur Hear J - Cardiovasc Pharmacother. 2021;7(2):104-111. Go to original source... Go to PubMed...
  63. Ahmed GM, Abed MN, Alassaf FA. Impact of calcium channel blockers and angiotensin receptor blockers on hematological parameters in type 2 diabetic patients. Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep 26. doi: 10.1007/s00210-023-02731-y. Online ahead of print. Go to original source... Go to PubMed...
  64. Mazer CD, Hare GMT, Connelly PW, et al. Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. Circulation. 2020;141(8):704-707. Go to original source... Go to PubMed...
  65. Docherty KF, Curtain JP, Anand IS, et al. Effect of dapagliflozin on anaemia in <scp>DAPA-HF</scp>. Eur J Heart Fail. 2021;23(4):617-628. Go to original source... Go to PubMed...
  66. Ahmed GM, Abed MN, Alassaf FA. An overview of the effects of sodium-glucose co-transporter-2 inhibitors on hematological parameters in diabetic patients. Iraqi J Pharm. 2023;20(1):65-71. Go to original source...
  67. Wang X, Zheng P, Huang G, Yet al. Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes. Clin Exp Med. 2018;18(4):473-480. Go to original source... Go to PubMed...
  68. Hasegawa T, Zhao J, Bieber B, et al. Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus. Kidney Blood Press Res. 2021;46(3):352-361. Go to original source... Go to PubMed...
  69. Aono M, Sato Y. Dipeptidyl peptidase 4 inhibitor linagliptin can decrease the dosage of erythropoiesis-stimulating agents in patients on hemodialysis. Ren Replace Ther. 2016;2(1):44. Go to original source...
  70. Shao S, Xu Q, Yu X, et al. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions. Pharmacol Ther. 2020;209:107503. Go to original source... Go to PubMed...
  71. Fiseha T, Adamu A, Tesfaye M, et al. Prevalence of anemia in diabetic adult outpatients in Northeast Ethiopia. Hirst JA, editor. PLoS One. 2019;14(9):e0222111. Go to original source... Go to PubMed...
  72. Lee H, Na W, Lee SB, et al. Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes. Front Physiol. 2019;10:1062. Go to original source... Go to PubMed...
  73. Pidcoke HF, Wade CE, Mann EA, et al. Anemia causes hypoglycemia in intensive care unit patients due to error in single-channel glucometers: Methods of reducing patient risk*. Crit Care Med. 2010;38(2):471-476. Go to original source... Go to PubMed...
  74. Christy AL, Manjrekar PA, Babu RP, et al. Influence of iron deficiency anemia on hemoglobin A1c levels in diabetic individuals with controlled plasma glucose levels. Iran Biomed J. 2014;18(2):88-93.
  75. Soliman AT, De Sanctis V, Yassin M, Soliman N. Iron deficiency anemia and glucose metabolism. Acta Biomed. 2017;88(1):112-118.
  76. Aggarwal N, Rai AK, Kupfer Y, et al. Immeasurable glycosylated haemoglobin: a marker for severe haemolysis. Case Reports. 2013;2013(aug08 1):bcr2013200307-bcr2013200307. Go to original source... Go to PubMed...
  77. Rossing P, Caramori ML, Chan JCN, et al. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5):1-127. Go to original source... Go to PubMed...
  78. Cerf ME. Healthy lifestyles and noncommunicable diseases: Nutrition, the life-course, and health promotion. Lifestyle Med. 2021;2(2). Go to original source...
  79. Drüeke TB. Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs). Ren Replace Ther. 2018;4(1):46. Go to original source...
  80. Bajaj S, Makkar BM, Abichandani VK, et al. Management of anemia in patients with diabetic kidney disease: A consensus statement. Indian J Endocrinol Metab. 2016;20(2):268-281. Go to original source... Go to PubMed...
  81. Petry CJ. Iron Supplementation in Pregnancy and Risk of Gestational Diabetes: A Narrative Review. Nutrients. 2022;14(22):4791. Go to original source... Go to PubMed...
  82. Zhuang T, Han H, Yang Z. Iron, Oxidative Stress and Gestational Diabetes. Nutrients. 2014;6(9):3968-3980. Go to original source... Go to PubMed...
  83. Michalak SS, Wolny-Rokicka E, Nowakowska E, et al. Clinical Implications of the Coexistence of Anemia and Diabetes Mellitus in the Elderly Population. Santulli G, editor. J Diabetes Res. 2021;2021:1-9. Go to original source... Go to PubMed...
  84. Ferrucci L, Balducci L. Anemia of Aging: The Role of Chronic Inflammation and Cancer. Semin Hematol. 2008;45(4):242-249. Go to original source... Go to PubMed...
  85. Macciò A, Madeddu C. Management of Anemia of Inflammation in the Elderly. Anemia. 2012;2012:1-20. Go to original source... Go to PubMed...
  86. Hung P, Yeh C, Hsiao C, et al. Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan. J Am Heart Assoc. 2021;10(14). Go to original source... Go to PubMed...
  87. Brar SK, Perveen S, Chaudhry MR, et al. Erythropoietin-Induced Hypertension: A Review of Pathogenesis, Treatment, and Role of Blood Viscosity. Cureus. 2021;13(1):e12804. Go to original source... Go to PubMed...
  88. Davidoviæ S, Babiæ N, Jovanoviæ S, et al. Serum erythropoietin concentration and its correlation with stage of diabetic retinopathy. BMC Ophthalmol. 2019;19(1):227. Go to original source... Go to PubMed...
  89. Ibrahim SL, Abed MN, Mohamed G, et al. Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel. Br J Cancer. 2023;128(5):896-906. Go to original source... Go to PubMed...
  90. Abed MN, Abdullah MI, Richardson A. Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells. J Ovarian Res. 2016;9(1):25. Go to original source... Go to PubMed...
  91. Abdullah MI, Abed MN, Richardson A. Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells. Sci Rep. 2017;8090. Go to original source... Go to PubMed...